List of Tables Table 01. Global Sales of Top 50 Anticancer Drugs, 2018 ($Million) Table 02. Russia Top 10 Cancer Drugs Sales, 2018 ($Million) Table 03. Netherlands Top 10 Cancer Drugs Sales, 2018 ($Million) Table 04. Switzerland Top 10 Cancer Drugs Sales, 2018 ($Million) Table 05. Sweden Top 10 Cancer Drugs Sales, 2018 ($Million) Table 06. Belgium Top 10 Cancer Drugs Sales, 2018 ($Million) Table 07. Austria Top 10 Cancer Drugs Sales, 2018 ($Million) Table 08. Norway Top 10 Cancer Drugs Sales, 2018 ($Million) Table 09. Denmark Top 10 Cancer Drugs Sales, 2018 ($Million) Table 10. Poland Top 10 Cancer Drugs Sales, 2018 ($Million) Table 11. Finland Top 10 Cancer Drugs Sales, 2018 ($Million) Table 12. Portugal Top 10 Cancer Drugs Sales, 2018 ($Million) Table 13. Greece Top 10 Cancer Drugs Sales, 2018 ($Million) Table 14. Ireland Top 10 Cancer Drugs Sales, 2018 ($Million) Table 15. Czech Republic Top 10 Cancer Drugs Sales, 2018 ($Million) Table 16. Hungary Top 10 Cancer Drugs Sales, 2018 ($Million) Table 17. Romania Top 10 Cancer Drugs Sales, 2018 ($Million) Table 18. Ukraine Top 10 Cancer Drugs Sales, 2018 ($Million) Table 19. Taiwan Top 10 Cancer Drugs Sales, 2018 ($Million) Table 20. Indonesia Top 10 Cancer Drugs Sales, 2018 ($Million) Table 21. New Zealand Top 10 Cancer Drugs Sales, 2018 ($Million) Table 22. Singapore Top 10 Cancer Drugs Sales, 2018 ($Million) Table 23. Malaysia Top 10 Cancer Drugs Sales, 2018 ($Million) Table 24. Vietnam Top 10 Cancer Drugs Sales, 2018 ($Million) Table 25. Myanmar Top 10 Cancer Drugs Sales, 2018 ($Million) Table 26. Sri Lanka Top 10 Cancer Drugs Sales, 2018 ($Million) Table 27. Macau Top 10 Cancer Drugs Sales, 2018 ($Million) Table 28. Nepal Top 10 Cancer Drugs Sales, 2018 ($Million) Table 29. Turkey Top 10 Cancer Drugs Sales, 2018 ($Million) Table 30. Venezuela Top 10 Cancer Drugs Sales, 2018 ($Million) Table 31. Colombia Top 10 Cancer Drugs Sales, 2018 ($Million) Table 32. Argentina Top 10 Cancer Drugs Sales, 2018 ($Million) Table 33. Iran Top 10 Cancer Drugs Sales, 2018 ($Million) Table 34. Israel Top 10 Cancer Drugs Sales, 2018 ($Million) Table 35. Chile Top 10 Cancer Drugs Sales, 2018 ($Million) Table 36. Algeria Top 10 Cancer Drugs Sales, 2018 ($Million) Table 37. Uae Top 10 Cancer Drugs Sales, 2018 ($Million) Table 38. Puerto Rico Top 10 Cancer Drugs Sales, 2018 ($Million) Table 39. Morocco Top 10 Cancer Drugs Sales, 2018 ($Million) Table 40. Costa Rica Top 10 Cancer Drugs Sales, 2018 ($Million) Table 41. Lebanon Top 10 Cancer Drugs Sales, 2018 ($Million) Table 42. Abbvie: Company Snapshot Table 43. Abbvie: Operating Segments Table 44. Abbott: Product Portfolio Table 45. Astellas: Company Snapshot Table 46. Astellas: Products And Services Table 47. Astellas: Product Portfolio Table 48. Astrazeneca: Company Snapshot Table 49. Astrazeneca: Operating Segments Table 50. Astrazeneca: Product Portfolio Table 51. Bristol-Myers Squibb: Company Snapshot Table 52. Bristol-Myers Squibb: Product Portfolio Table 53. Celgene: Company Snapshot Table 54. Celgene: Operating Segments Table 55. Celgene : Product Type Portfolio Table 56. Roche: Company Snapshot Table 57. Roche: Operating Segments Table 58. Roche: Product Type Portfolio Table 59. J&J: Company Snapshot Table 60. J&J: Operating Segments Table 61. J&J: Product Type Portfolio Table 62. Merck: Company Snapshot Table 63. Merck: Operating Segments Table 64. Merck: Product Portfolio Table 65. Novartis: Company Snapshot Table 66. Novartis: Operating Segments Table 67. Novartis: Product Portfolio Table 68. Pfizer: Company Snapshot Table 69. Pfizer: Operating Segments Table 70. Pfizer: Product Portfolio
List of Figures Figure 01. Top Investment Pockets, 2018 Figure 02. Top Player Positioning, 2018 Figure 03. Moderate Barganing Power of Buyers Figure 04. High Barganing Power of Suppliers Figure 05. Moderate Threat of Substitution Figure 06. Moderate Threat of New Entrants Figure 07. High Competitive Rivalry Figure 08. World Population Aged 65 And Over (%) Figure 09. Impact Analysis Figure 10. European Geriatric Population (Above 65 Years), 2017 Figure 11. Russia Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 12. Netherlands Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 13. Switzerland Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 14. Sweden Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 15. Belgium Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 16. Austria Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 17. Norway Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 18. Denmark Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 19. Poland Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 20. Finland Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 21. Portugal Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 22. Greece Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 23. Ireland Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 24. Czech Republic Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 25. Hungary Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 26. Romania Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 27. Ukraine Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 28. Taiwan Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 29. Indonesia Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 30. New Zealand Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 31. Singapore Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 32. Malaysia Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 33. Vietnam Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 34. Myanmar Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 35. Sri Lanka Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 36. Macau Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 37. Nepal Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 38. Turkey Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 39. Venezuela Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 40. Colombia Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 41. Argentina Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 42. Iran Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 43. Israel Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 44. Chile Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 45. Algeria Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 46. Uae Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 47. Puerto Rico Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 48. Morocco Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 49. Costa Rica Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 50. Lebanon Top 10 Cancer Drugs Market, 2018-2026 ($Million) Figure 51. Abbvie: Net Sales, 2015-2017 ($Million) Figure 52. Abbvie: Revenue Share By Segment, 2017 (%) Figure 53. Abbvie: Revenue Share By Region, 2017 (%) Figure 54. Astellas: Sales, 2015-2017 ($Million) Figure 55. Astellas: Sales Share By Products And Services, 2017 (%) Figure 56. Astellas: Revenue Share By Region, 2017 (%) Figure 57. Astrazeneca: Revenue, 2015-2017 ($Million) Figure 58. Astrazeneca: Revenue Share By Region, 2017 (%) Figure 59. Revenue, 2015-2017 ($Million) Figure 60. Bristol-Myers Squibb: Revenue Share By Region, 2017 (%) Figure 61. Celgene: Revenue, 2015-2017 ($Million) Figure 62. Celgene: Revenue Share By Segment, 2017 (%) Figure 63. Celgene: Revenue Share By Region, 2017 (%) Figure 64. Roche: Net Sales, 2015-2017 ($Million) Figure 65. Roche: Revenue Share By Segment, 2017 (%) Figure 66. Roche: Revenue Share By Region, 2017 (%) Figure 67. J&J: Revenue, 2015-2017 ($Million) Figure 68. J&J: Revenue Share By Segment, 2017 (%) Figure 69. J&J: Revenue Share By Region, 2017 (%) Figure 70. Merck: Net Sales, 2015-2017 ($Million) Figure 71. Merck: Net Sales By Segment, 2017 (%) Figure 72. Merck: Net Sales By Region, 2017 (%) Figure 73. Net Sales, 2015-2017 ($Million) Figure 74. Novartis: Revenue Share By Segment, 2017 (%) Figure 75. Novartis: Revenue Share By Region, 2017 (%) Figure 76. Pfizer: Revenue, 2015-2017 ($Million) Figure 77. Pfizer: Revenue Share By Segment, 2017 (%) Figure 78. Pfizer: Revenue Share By Region, 2017 (%)
